SCHEMBL3164161

SCHEMBL3164161

O=c1[c]c(O)c2ccccc2o1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA12 O43570 3/20 0.48
CA9 Q16790 3/20 0.48
CA1 P00915 2/20 0.48
MAOA P21397 5/20 0.48
KDM4E B2RXH2 5/20 0.48
CYP3A4 P08684 4/20 0.48
ALDH1A1 P00352 4/20 0.48
SMN1; SMN2 Q16637 3/20 0.48
HPGD P15428 2/20 0.48
HSD17B10 Q99714 2/20 0.48
GLA P06280 1/20 0.48
MAPT P10636 1/20 0.48
PGAM1 P18669 1/20 0.48
CASP1 P29466 1/20 0.48
CASP7 P55210 1/20 0.48
MEN1 O00255 3/20 0.44
MAPK1 P28482 3/20 0.44
KMT2A Q03164 3/20 0.44
LMNA P02545 2/20 0.44
TP53 P04637 2/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7796860 0.77 KDM4E (0.55) CA12CA9MAOAKDM4ECYP3A4
SCHEMBL2192615 0.76 KDM4E (0.48) CA12CA9CA1MAOAKDM4E
SCHEMBL4499932 0.76 KDM4E (0.50) CA12CA9CA1MAOAKDM4E
SCHEMBL16742386 0.73 DDR2 (0.49) CA12CA9CA1MAOAKDM4E
SCHEMBL10345473 0.72 MAOA (0.46) CA12CA9MAOAKDM4ECYP3A4
SCHEMBL1053171 0.72 GAA (0.46) CA12CA9CA1MAOAKDM4E
SCHEMBL8945543 0.70 ALDH1A1 (0.40) CA12CA9KDM4EALDH1A1MAPT
SCHEMBL2215928 0.69 CA12 (0.43) CA12CA9CA1MAOAKDM4E
SCHEMBL20607233 0.68 MAPT (0.42) MAOAKDM4ECYP3A4ALDH1A1SMN1; SMN2
SCHEMBL29379994 0.67 KDM4E (0.69) CA12CA9KDM4ECYP3A4ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10596153-B2 Antimicrobial agents and the method of synthesizing the antimicrobial agents ARKANSAS STATE UNIVERSITY-JONESBORO (US) 2020-03-24 US claimed
EP-1848725-B1 UNSATURATED DIPYRROMETHENE-BORON BOROCARBONS CENTRE NAT RECH SCIENT (FR) 2013-11-27 EP claimed
US-7897786-B2 For fluorescent or electroluminescent analysis; chromophore substituents with wavelength close to ultraviolet radiation range CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (C.N.R.S.) (FR) 2011-03-01 US claimed
US-20080102534-A1 Unsaturated Dipyrromethene-Boron Borocarbons UNIVERSITE LOUISE PASTEUR DE STRASBOURG (FR) 2008-05-01 US claimed
EP-1383756-B1 COUMARIN DERIVATIVES TO BE USED AS ANTICOAGULANTS ARYX THERAPEUTICS (US) 2008-03-05 EP claimed
WO-1999001442-A1 TRIAZINE DERIVATIVES AND THEIR USE AS ANTIBACTERIAL AGENTS ZENECA LIMITED (GB) 1999-01-14 WO claimed
JP-11158169-A None JP disclosed
WO-2023131651-A1 NOVEL FLUORESCENT BODIPY COMPOUNDS DISPLAYING ABSORPTION AND EMISSION IN THE NIR REGION UNIVERSITE DE STRASBOURG (FR) 2023-07-13 WO disclosed
EP-4209496-A1 NOVEL FLUORESCENT BODIPY COMPOUNDS DISPLAYING ABSORPTION AND EMISSION IN THE NIR REGION Université de Strasbourg (FR) 2023-07-12 EP disclosed
EP-3154341-B1 DIFENACOUM CONTAINING COMPOSITION, RODENTICIDAL BAIT AND PROCESS FOR CONTROLLING TARGET RODENT PESTS VETAGRO SUP (FR) 2018-11-07 EP disclosed
US-9706770-B2 Rodenticide bait comprising difenacoum and method for controlling target rodent pests LIPHATECH (FR) 2017-07-18 US disclosed
US-20170105408-A1 RODENTICIDE BAIT COMPRISING DIFENACOUM AND METHOD FOR CONTROLLING TARGET RODENT PESTS VETAGRO SUP (FR) 2017-04-20 US disclosed
EP-3154341-A1 RODENTICIDE BAIT COMPRISING DIFENACOUM AND METHOD FOR CONTROLLING TARGET RODENT PESTS Liphatech (FR) 2017-04-19 EP disclosed
EP-1383756-B1 COUMARIN DERIVATIVES TO BE USED AS ANTICOAGULANTS ARYX THERAPEUTICS (US) 2008-03-05 EP disclosed
CN-1950353-A Materials and methods for treating coagulation disorders ARYX THERAPEUTICS (US) 2007-04-18 CN disclosed
JP-H11158169-A NOVEL HYDROXY AND POLYHYDROXY DERIVATIVE OF COUMARIN AND THEIR PRODUCTION PLIVA PHARMACEUT KEMIJSKA PREHRAMBENA I KOZMET IND DIONICKO DRUSTVO 1999-06-15 JP disclosed
WO-1999001442-A1 TRIAZINE DERIVATIVES AND THEIR USE AS ANTIBACTERIAL AGENTS ZENECA LIMITED (GB) 1999-01-14 WO disclosed
EP-0175466-B1 SEPARATION OF ISOMERS IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1989-09-20 EP disclosed
US-4788297-A Separation of isomers IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1988-11-29 US disclosed
EP-0175466-A2 Separation of isomers IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1986-03-26 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080102534-A1 Unsaturated Dipyrromethene-Boron Borocarbons NPBWR1, DBN1, BOD1L1 CA12 1503/4885CA9 2329/4885CA1 2168/4885
US-20170105408-A1 RODENTICIDE BAIT COMPRISING DIFENACOUM AND METHOD FOR CONTROLLING TARGET RODENT PESTS DHCR24, CYP2E1, CYP8B1 CA12 4860/4885CA9 4758/4885CA1 4314/4885
US-10596153-B2 Antimicrobial agents and the method of synthesizing the antimicrobial agents AADAC, AAAS, PAM CA12 4707/4885CA9 4279/4885CA1 4700/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.